Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients

Journal of Neurosurgery

Volumn 118, Issue 4, 2013, Pages 786-798

  Tanaka, Shota ^a   Meyer, Fredric B ^a   Buckner, Jan C ^a   Uhm, Joon H ^a   Yan, Elizabeth S ^a   Parney, Ian F ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chemotherapy; Elderly; Glioblastoma; Oncology; Radiation therapy; Resection

Indexed keywords

TEMOZOLOMIDE;

ADJUVANT CHEMORADIOTHERAPY; AGED; ARTICLE; BIOPSY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CRANIOTOMY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE COURSE; ELDERLY CARE; FEMALE; GLIOBLASTOMA; HEADACHE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KARNOFSKY PERFORMANCE STATUS; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SEIZURE; TUMOR VOLUME; VOMITING;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; DRUG THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEUROSURGICAL PROCEDURES; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84875855960     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.10.JNS112268     Document Type: Article

References (50)

1. Barnholtz-Sloan JS, Williams VL, Maldonado JL, Shahani D, Stockwell HG, Chamberlain M, et al: Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 108:642-648, 2008
2. Batchelor TT, Betensky RA, Esposito JM, Pham LD, Dorfman MV, Piscatelli N, et al: Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 10: 228-233, 2004
3. Bernstein M, Parrent AG: Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81:165-168, 1994
4. Brandes AA, Franceschi E, Tosoni A, Benevento F, Scopece L, Mazzocchi V, et al: Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115:3512-3518, 2009
5. Brandes AA, Monfardini S: The treatment of elderly patients with high-grade gliomas. Semin Oncol 30 (6 Suppl 19):58-62, 2003
6. Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A, et al: A prospective study on glioblastoma in the elderly. Cancer 97:657-662, 2003
7. Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, et al: Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol 76: 283-291, 2006
8. Buckner JC: Factors influencing survival in high-grade gliomas. Semin Oncol 30 (6 Suppl 19):10-14, 2003
9. Central Brain Tumor Registry of the United States: Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2005. (http://www.cbtrus.org/reports/2009-NPCR-04-05/CBTRUSNPCR2004- 2005-Report-.pdf) [Accessed October 22, 2012]
10. Chaichana KL, Chaichana KK, Olivi A, Weingart JD, Bennett R, Brem H, et al: Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg 114: 587-594, 2011
11. Chang SM, Parney IF, McDermott M, Barker FG II, Schmidt MH, Huang W, et al: Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175-1181, 2003
12. Combs SE, Wagner J, Bischof M, Welzel T, Wagner F, Debus J, et al: Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys 70:987-992, 2008
13. de Robles P, Cairncross G: Glioblastoma in the elderly: an age-old problem. Ann Neurol 64:597-599, 2008
14. DeAngelis LM, Burger PC, Green SB, Cairncross JG: Malignant glioma: who benefits from adjuvant chemotherapy? Ann Neurol 44:691-695, 1998
15. Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78: 767-775, 1993
16. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993
17. Fiorica F, Berretta M, Colosimo C, Stefanelli A, Ursino S, Zanet E, et al: Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide. Arch Gerontol Geriatr 51:31-35, 2010
18. Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, et al: Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res 16: 2443-2449, 2010
19. Iwamoto FM, Cooper AR, Reiner AS, Nayak L, Abrey LE: Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007). Cancer 115:3758-3766, 2009
20. Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE: Patterns of care in elderly glioblastoma patients. Ann Neurol 64:628-634, 2008
21. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, et al: Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527-1535, 2007
22. Kelly PJ, Hunt C: The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery 34: 62-67, 1994
23. Kim JE, Kim DG, Paek SH, Jung HW: Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta Neurochir (Wien) 145:547-555, 2003
24. Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G III, Erickson RK, Hekmatpanah J, et al: Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41:1028-1038, 1997
25. Kreth FW, Warnke PC, Scheremet R, Ostertag CB: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762-766, 1993
26. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001
27. Lamborn KR, Chang SM, Prados MD: Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 6:227-235, 2004
28. Laperriere N, Zuraw L, Cairncross G: Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 64:259-273, 2002
29. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467-473, 2003
30. Lutterbach J, Sauerbrei W, Guttenberger R: Multivariate analysis of prognostic factors in patients with glioblastoma. Strahlenther Onkol 179:8-15, 2003
31. Mangiola A, Maira G, De Bonis P, Porso M, Pettorini B, Sabatino G, et al: Glioblastoma multiforme in the elderly: a therapeutic challenge. J Neurooncol 76:159-163, 2006
32. McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A: Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65:463-470, 2009
33. Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 88:97-103, 2008
34. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, et al: Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24:2563-2569, 2006
35. Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH: Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42:981-987, 1998
36. Nitta T, Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75:2727-2731, 1995
37. Oszvald A, Güresir E, Setzer M, Vatter H, Senft C, Seifert V, et al: Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age. Clinical article. J Neurosurg 116:357-364, 2012
38. Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, et al: Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583-1588, 2004
39. Rosenblum ML, Gerosa M, Dougherty DV, Reese C, Barger GR, Davis RL, et al: Age-related chemosensitivity of stem cells from human malignant brain tumours. Lancet 1:885-887, 1982
40. Sanai N, Berger MS: Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753-764, 2008
41. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044-1056, 1998
42. Scott JG, Suh JH, Elson P, Barnett GH, Vogelbaum MA, Peereboom DM, et al: Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol 13:428-436, 2011
43. Sijben AE, McIntyre JB, Roldán GB, Easaw JC, Yan E, Forsyth PA, et al: Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol 89:97-103, 2008
44. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, et al: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26:239-244, 1993
45. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011-1018, 2002
46. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006
47. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
48. Tait MJ, Petrik V, Loosemore A, Bell BA, Papadopoulos MC: Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Br J Neurosurg 21:496-500, 2007
49. Tilgner J, Herr M, Ostertag C, Volk B: Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis-influence of clinical factors. Neurosurgery 56:257-265, 2005
50. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS: Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278-299, 2002